Suppr超能文献

采用纸片扩散法检测来自各种临床样本的菌株中产超广谱β-内酰胺酶(ESBL)的情况。

Detection of extended-spectrum beta-lactamase (ESBL) production by disc diffusion method among species from various clinical samples.

作者信息

Kothari Ashish, Kumar Shailesh, Omar Balram Ji, Kiran Kamini

机构信息

Department of Microbiology, All India Institute of Medical Science, Rishikesh, Uttarakhand, India.

Department of Dentistry, All India Institute of Medical Science, Rishikesh, Uttarakhand, India.

出版信息

J Family Med Prim Care. 2020 Feb 28;9(2):683-693. doi: 10.4103/jfmpc.jfmpc_570_19. eCollection 2020 Feb.

Abstract

AIM/OBJECTIVES: This study was aimed to detect extended-spectrum beta-lactamase (ESBL) producing species isolated from various clinical samples by phenotypic methods with their susceptibility testing.

MATERIALS AND METHODS

Hundred isolates were taken from various clinical samples of patients attending outpatient department (OPD) and inpatient department (IPD). Antimicrobial susceptibility test and ESBL detection were assessed using CLSI guidelines on Mueller Hinton agar.

RESULTS

Out of 100 isolates, 46 isolates were from female and 54 were from male patients. More cases of pseudomonal infection were in the age group between 46 and 60 years (34%), and 59% of species were isolated from patients belongs to urban areas and the rest 41% were from rural. The isolates collected from OPD were 61% and rest 39% from IPD. species showed maximum resistance to cephalosporin group of antibiotics and showed least resistance to imipenem, and showed 100% susceptibility to colistin. ESBL production was detected in 42% of total isolates.

CONCLUSION

The present study highlights that the species remains an important cause of nosocomial infections. ESBL producing species continue to be an important organism causing life-threatening infections. Multidrug resistance was seen in most of the strains. Resistance is developing even to combination of ceftazidime clavulanic acid. Resistance is developing to last resort of antibiotic, i.e. imipenem also. This gives the alarming signal for the future, making the therapeutic options more difficult. Strict infection control measures are to be taken to contain this so-called water and soil organisms as .

摘要

目的

本研究旨在通过表型方法及其药敏试验检测从各种临床样本中分离出的产超广谱β-内酰胺酶(ESBL)的菌株。

材料与方法

从门诊(OPD)和住院部(IPD)患者的各种临床样本中采集了100株分离株。根据CLSI指南在穆勒-欣顿琼脂上进行药敏试验和ESBL检测。

结果

在100株分离株中,46株来自女性患者,54株来自男性患者。46至60岁年龄组的假单胞菌感染病例较多(34%),59%的菌株分离自城市地区的患者,其余41%来自农村。从OPD收集的分离株占61%,其余39%来自IPD。菌株对头孢菌素类抗生素耐药性最高,对亚胺培南耐药性最低,对黏菌素敏感性达100%。42%的分离株检测到产ESBL。

结论

本研究强调该菌株仍然是医院感染的重要原因。产ESBL的菌株仍然是导致危及生命感染的重要病原体。大多数菌株出现多重耐药。甚至对头孢他啶-克拉维酸联合用药也产生了耐药性。对最后的抗生素防线即亚胺培南也产生了耐药性。这为未来敲响了警钟,使治疗选择更加困难。必须采取严格的感染控制措施来遏制这种所谓的“水土不服”的病原体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5225/7114052/89df85dcaba0/JFMPC-9-683-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验